Health
Resveratrol shows potential as SARS-CoV-2 antiviral, study finds – News-Medical.Net
A recent study reveals that resveratrol, a phenolic compound produced by spermatophytes, can inhibit the viral replication SARS-CoV-2.
A recent study published in the journal Phytotherapy Research reveals that resveratrol, a phenolic compound produced by spermatophytes, can inhibit the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of coronavirus disease 2019 (COVID-19), in in vitro setups.
As of November 26, 2020, more than 61.1 million confirmed cases of COVID-19, and more than 1.41 million deaths, have been reported globally by the World Health Organization. Although milder…
-
General10 hours agoCampers evacuated, residents on alert as Moreton Island bushfire intensifies
-
Business18 hours agoBell Potter names the best ASX shares to buy in October
-
Noosa News22 hours agoResilience features in Sunshine Coast Open House
-
Noosa News16 hours agoPerth Royal Show vendors upset by price hikes, say crowds are down in 2025